Cefazolin vs Moxalactam? A Double-blind Randomized Trial of Cephalosporins in Head and Neck Surgery
James T. Johnson, Victor L. Yu, E. N. Myers, Robin L. Wagner, B. A. Sigler
Abstract
James T. Johnson, Victor L. Yu, E. N. Myers, Robin L. Wagner, B. A. Sigler
Abstract
Cefazolin and moxalactam were compared in a prospective randomized double-blind trial of 118 patients undergoing oncologic head and neck surgery. Both antibiotics were given 2 g every four hours for four doses. Five infections were encountered in the cefazolin group (8.5%) and two infections in the moxalactam group (3.4%); this difference was not statistically significant. This assessment does not indicate, however, that the two regimens are equally efficacious.
OpenAlex reports 37 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Cefazolin and moxalactam were compared in a prospective randomized double-blind trial of 118 patients undergoing oncologic head and neck surgery. Both antibiotics were given 2 g every four hours for four doses. Five infections were encountered in the cefazolin group (8.5%) and two infections in the moxalactam group (3.4%); this difference was not statistically significant. This assessment does not indicate, however, that the two regimens are equally efficacious.
Key concepts: Moxalactam, Cefazolin, Medicine, Cephalosporin, Surgery, Anesthesia, Randomized controlled trial, Latamoxef